Adjuvant hyperthermic intraperitoneal chemotherapy in patients with locally advanced colon cancer (COLOPEC): a multicentre, open-label, randomised trial
Charlotte E.L. Klaver(University of Amsterdam), Jeroen Heemskerk, Marjolein Diepeveen, D. D. E. Zimmerman(Elisabeth-TweeSteden Ziekenhuis), Henderik L. van Westreenen(Isala), Jacobus W. A. Burger(Radboud University Nijmegen), Marinus J. Wiezer(St. Antonius Ziekenhuis), Jan‐Willem T. Dekker(Reinier de Graaf Hospital), Djamila Boerma(St. Antonius Ziekenhuis), Walter J.A. Brokelman, Floris Ferenschild(Erasmus MC Cancer Institute), Esther C. J. Consten(University Medical Center Groningen), Anthony W. H. van de Ven, Frank C. den Boer(Zaans Medisch Centrum), Huib A. Cense(Rode Kruis Ziekenhuis), Wilhelmina M. U. van Grevenstein(University Medical Center Utrecht), Alexandra Brandt(Erasmus University Rotterdam), Eino B. van Duyn(Medisch Spectrum Twente), Cornelis J.A. Punt(Utrecht University), Jennifer Demelinne, Jurriaan B. Tuynman(Amsterdam Neuroscience), Johanne G. Bloemen(Radboud University Nijmegen), Lotte Schoonderwoerd(Ziekenhuis Bernhoven), Rogier M. P. H. Crolla(Amphia Ziekenhuis), Willem A. Bemelman(Vrije Universiteit Amsterdam), Pauline Evers, Karin K. van Diepen, Annette A. van Zweeden(Ziekenhuis Amstelland), Erwin van der Harst(Radboud University Nijmegen), Johannes Crezee(Amsterdam UMC Location University of Amsterdam), Patrick Hemmer(University Medical Center Groningen), Ignace H. J. T. de Hingh(Radboud University Nijmegen), Pieter J. Tanis(Erasmus MC), D D Wisselink(Amsterdam University Medical Centers), Vivian P. Bastiaenen(Amsterdam University Medical Centers), Daan ten Bokkel Huinink(Diakonessenhuis hospital), Marcel G. W. Dijkgraaf(University of Amsterdam), Hans F. J. Fabry(Bravis Ziekenhuis), Esther D. van den Ende, Pétur Snæbjörnsson(University of Iceland), Arend G. J. Aalbers(The Netherlands Cancer Institute), Sebastiaan Festen(OLVG), Anna A. W. van Geloven, Caroline S. Andeweg, Marc J. van Det(Ziekenhuis Groep Twente), Jarmila D.W. van der Bilt(Flevoziekenhuis), Geert‐Jan Creemers, André J. A. Bremers(Radboud University Nijmegen), Niels F.M. Kok(The Netherlands Cancer Institute), Gijsbert D. Musters(Amsterdam University Medical Centers)
Cited by 326
Related Papers
Colorectal cancer
|The Lancet|2019|5k
STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD
|Gastroenterology|2021|2.6k
Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial
|The Lancet Oncology|2015|2.6k
Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target
|The American Journal of Gastroenterology|2015|1.8k
Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer
|New England Journal of Medicine|2018|1.4k